Instructor in Medicine
Division of Infectious Diseases
John T. Milliken Department of Internal Medicine
Washington University School of Medicine
Dr. Anne Mobley Butler is an epidemiologist with a primary appointment in the Division of Infectious Diseases at Washington University School of Medicine. Her pharmacoepidemiology research focuses on the treatment and prevention of common infections, including antibiotic and vaccine utilization, effectiveness, safety, and related outcomes. Her work involves the application of epidemiologic study designs and analytic methods to highly detailed, clinical and administrative data that are captured on patients as part of routine clinical care. Dr. Butler’s research utilizes data from various national databases including US commercial claims, Medicare, Medicaid, United States Renal Database System, Flatiron, and other clinical cohorts. Given that various patient populations are rarely included in clinical trials, results generated from these studies provide much needed evidence to inform decisions related to clinical practice, health policy, and quality improvement interventions.
See Dr. Butler’s full list of publications in PubMed.
Butler AM, Cetin K, Hernandez RK, Overman RA, Kim J, Reams BD, Hirsch BR, Abernethy AP, Liede A, Brookhart MA. Treatment dynamics of bone-targeting agents among men with bone metastases from prostate cancer in the United States. In press at Pharmacoepidemiology and Drug Safety.
Vielot NA, Butler AM, Brookhart MA, Becker-Dreps S, Smith JS. Patterns of use of human papillomavirus and other adolescent vaccines in the United States. Journal of Adolescent Health 2017. DOI: 10.1016/j.jadohealth.2017.05.016
Layton JB, Butler AM, Li D, Boggess KA, Weber DJ, McGrath LJ, Becker-Dreps. Prenatal pertussis immunization and risk of maternal and newborn adverse events. Vaccine 2017 Jul 24;35(33):4072-4078. doi: 10.1016/j.vaccine.2017.06.071. Epub 2017 Jun 29.
Butler AM, Layton JB, Li D, Hudgens MG, Boggess KA, McGrath LJ, Becker-Dreps S. Predictors of low uptake of prenatal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis immunization in privately-insured women in the United States. Obstetrics and Gynecology 2017; 129(4):629-637.
Freburger JK, Ellis AR, Wang L, Butler AM, Kshirsagar AV, Winkelmayer WC, MA Brookhart. Comparative effectiveness of iron and erythropoiesis-stimulating agent dosing on health-related quality of life in patients receiving hemodialysis. American Journal of Kidney Diseases 2016 Feb;67(2):271-82. doi: 10.1053/j.ajkd.2015.09.011. Epub 2015 Oct 23.
Butler AM, Olshan AF, Kshirsagar AV, Wang L, Nielsen ME, Wheeler SB, Brookhart MA. Trends in anemia management in hemodialysis patients with cancer. American Journal of Nephrology 2015; 42:206-215.
Butler AM, Olshan AF, Kshirsagar AV, Wang L, Edwards JK, Nielsen ME, Wheeler SB, Brookhart MA. Cancer incidence among US Medicare end-stage renal disease patients receiving hemodialysis, 1996-2009. American Journal of Kidney Diseases 2015; 65(5):763-772.
Petrick JL*, Wyss AB*, Butler AM*, Cummings C, Sun X, Poole C, Smith JS, Olshan AF. Prevalence of human papillomavirus among oesophageal squamous cell carcinoma cases: systematic review and meta-analysis. British Journal of Cancer 2014; 110(9):2369-2377. (*indicates first joint authors)
Butler AM, Kshirsagar AV, Brookhart MA. Opioid use in the U.S. hemodialysis population. American Journal of Kidney Diseases 2014; 63:171-173.
Butler AM, Olsen MA, Merz LR, Guth RM, Woeltje KF, Camins BC, Fraser VJ. Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort. Infection Control and Hospital Epidemiology 2010; 31:28-35.
Butler AM, Williams P, Howland L, Storm, D, Hutton N, Seage, G. The impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection. Pediatrics 2009; 123:935-943.